Insmed Inc
NASDAQ:INSM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Insmed Inc
NASDAQ:INSM
|
US |
|
L
|
Lockheed Martin Corp
XMUN:LOM
|
US |
|
C
|
CMOC Group Ltd
XMUN:D7N
|
CN |
|
Avricore Health Inc
F:8VP1
|
CA |
|
C
|
CMOC Group Ltd
OTC:CMCLF
|
CN |
|
P
|
PVH Corp
F:PVH
|
US |
|
Breville Group Ltd
F:HDE
|
AU |
|
A
|
AES Corp
DUS:AES
|
US |
|
T
|
Thai Vegetable Oil PCL
SET:TVO
|
TH |
|
Otter Tail Corp
NASDAQ:OTTR
|
US |
Intrinsic Value
Is INSM undervalued or overvalued?
See the intrinsic value estimate for Insmed Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Insmed Does
Insmed is a biopharmaceutical company that develops and sells medicines for serious, chronic diseases with few good treatment options, especially rare lung and inflammatory disorders. Its lead products are inhaled and oral therapies used by patients with conditions such as non-tuberculous mycobacterial lung disease and bronchiectasis, where infection and airway damage make breathing harder and daily care more complex.
- Headquarters
- United States of America US
- Employees
- 1 664
- IPO date
- Feb 15, 1991
Insmed has a narrow economic moat
Patents and legal protection against competing copies prevent rivals from freely copying Insmed’s medicines and undercutting their prices. These protections give Insmed room to earn returns from treatments developed for serious lung diseases.
Read the full moat analysis
Revenue & Expenses Breakdown
Insmed Inc
Earnings Waterfall
Insmed Inc
The intrinsic value for Insmed Inc (INSM) under the Base Case is hidden USD.
Compared with the current market price of 109.91 USD, the stock appears hidden.